Investigating genetic factors in schizophrenia development
Common schizophrenia variants functioning in developmental human cortical interneurons
This study is looking at how certain genes linked to schizophrenia affect the growth of important brain cells, which could help us understand more about the condition and its genetic risks for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11078258 on NIH RePORTER |
What this research studies
This research focuses on understanding how specific genetic variants associated with schizophrenia affect the development of certain brain cells known as cortical interneurons. By utilizing advanced techniques like CRISPR and 3D chromatin interaction analysis, the study aims to uncover how these genetic factors influence gene expression during critical developmental stages. The research will analyze human fetal brain cells to determine the timing and impact of these genetic variants, which could provide insights into the biological mechanisms underlying schizophrenia. Patients may benefit from a deeper understanding of the genetic risks associated with this disorder.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals under 21 years old who may have a family history of schizophrenia or related neurodevelopmental disorders.
Not a fit: Patients who are over 21 years old or do not have a genetic predisposition to schizophrenia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for early diagnosis and targeted interventions for schizophrenia.
How similar studies have performed: Previous research has shown promising results in understanding genetic influences on neurodevelopmental disorders, suggesting that this approach could yield valuable insights.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Chung, Sangmi — Rutgers Biomedical and Health Sciences
- Study coordinator: Chung, Sangmi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.